Influence of Helicobacter pylori infection persistence on bcl-2 expression in gastric mucosa inflammatory cells.

Chronic Helicobacter (H.) pylori infection is an etiological factor related to gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. The expression of bcl-2 protein significantly decreases as the grade of MALT lymphoma advances. The aim of this study was to evaluate bcl-2 expression in inflammatory cells in lamina propria in gastric biopsy samples collected from two groups of patients with chronic gastritis divided on the basis of the success or failure of H. pylori eradication. Sixty-five patients with chronic gastritis were divided into two groups of 45 and 20 patients according to their therapeutic response. The gastric mucosa samples were analyzed histologically in both groups of patients before and after standard therapy (for eradicated, after one therapeutic cycle; and for non-eradicated, after three therapeutic cycles) for H. pylori density, urease activity and bcl-2 expression. In the eradicated group of patients, H. pylori eradication was accompanied by significantly lower grades of bacterial colonization and lower urease activity in the corpus and antrum. Bcl-2 expression in inflammatory cells showed no statistically significant changes in either patient group at either location. There was no between-group difference in bcl-2 expression either. In conclusion, persistent long-lasting H. pylori infection is associated with higher grades of bacterial colonization and higher urease activity but not with bcl-2 expression in inflammatory cells.

[1]  M. Nasu,et al.  Antibiotic-induced apoptosis in human activated peripheral lymphocytes. , 2005, International journal of antimicrobial agents.

[2]  F. DeLeo,et al.  An apoptosis differentiation programme in human polymorphonuclear leucocytes. , 2004, Biochemical Society transactions.

[3]  K. Higuchi,et al.  Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. , 2003, Hepato-gastroenterology.

[4]  S. Edwards,et al.  Anaplasma phagocytophilum Reduces Neutrophil Apoptosis In Vivo , 2003, Infection and Immunity.

[5]  E. Lander,et al.  Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Ash A. Alizadeh,et al.  Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Jung Mogg Kim,et al.  Caspase‐3 Activity and Expression of Bcl‐2 Family in Human Neutrophils by Helicobacter pylori Water‐Soluble Proteins , 2001, Helicobacter.

[8]  P. Auberger,et al.  Helicobacter pylori Lipopolysaccharide Hinders Polymorphonuclear Leucocyte Apoptosis , 2001, Laboratory Investigation.

[9]  J. S. Kim, J. M. Kim, H. C. Jung, I. S. Song, C. Y Inhibition of Apoptosis in Human Neutrophils by Helicobacter pylori Water-Soluble Surface Proteins , 2001 .

[10]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[11]  F. Karayel,et al.  Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas , 1999, Pathology & Oncology Research.

[12]  R. Warnke,et al.  Helicobacter pylori infection and gastric lymphoma. , 1994, The New England journal of medicine.

[13]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[14]  Alter Mj,et al.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.

[15]  J. Parsonnet,et al.  Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. , 1991, Journal of the National Cancer Institute.

[16]  G. A. Alexander,et al.  Association of Helicobacter pylori infection with gastric cancer. , 2000, Military medicine.

[17]  M. Farthing Helicobacter pylori infection: an overview. , 1998, British medical bulletin.